Vaxcyte, Inc.PCVXNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank38
3Y CAGR-12.0%
5Y CAGR-17.0%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-12.0%/yr
vs +71.0%/yr prior
5Y CAGR
-17.0%/yr
Recent acceleration
Acceleration
-83.0pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 39.25% |
| 2024 | 53.05% |
| 2023 | 52.47% |
| 2022 | 57.61% |
| 2021 | 72.86% |
| 2020 | 99.78% |
| 2019 | 35.75% |
| 2018 | 6.74% |
| 2017 | 0.00% |